Searching for selective inhibitors of matrix metalloproteinase type 2 in a series of benzoylamino (phenylsulfonyl)-substituted cyclic amino acid derivatives
- 作者: Grigorkevich O.S1, Mokrov G.V1, Zolotov N.N1, Barchukov V.V1, Kryzhanovskii S.A1, Gudasheva T.A1
-
隶属关系:
- Zakusov Institute of Pharmacology
- 期: 卷 23, 编号 11 (2020)
- 页面: 22-27
- 栏目: Articles
- URL: https://journals.eco-vector.com/1560-9596/article/view/112795
- DOI: https://doi.org/10.29296/25877313-2020-11-04
- ID: 112795
如何引用文章
详细
全文:

作者简介
O. Grigorkevich
Zakusov Institute of PharmacologyJunior Research Scientist Moscow
G. Mokrov
Zakusov Institute of PharmacologyPh.D. (Chem.) Moscow
N. Zolotov
Zakusov Institute of PharmacologyDr.Sc. (Biol.), Professor Moscow
V. Barchukov
Zakusov Institute of PharmacologyResearch Scientist Moscow
S. Kryzhanovskii
Zakusov Institute of PharmacologyDr.Sc (Med.) Moscow
T. Gudasheva
Zakusov Institute of PharmacologyDr.Sc. (Biol.), Professor, Corresponding Member of the RAS Moscow
参考
- Всемирная организация здравоохранения: [сайт]. URL: https://www.who.mt/ru/news-room/fact-sheets/detail/cardio-vascular-diseases-(cvds) (дата обращения 28.02.2020).
- Spinale F.G. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol. Rev. 2007; 87: 1285-1342.
- Simova J., Skvor J., Slovak D., et al. Serum Levels of Matrix Metalloproteinases 2 and 9 in Patients with Acute Myocardial Infarction. Folia Biol. 2013; 59: 181-187.
- Hori M., Nishida K. Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc. Res. 2009; 81(3): 457-464.
- Creemers E., Cleutjens J., Smits J., et al. Matrix Metalloproteinase Inhibition After Myocardial Infarction: A New Approach to Prevent Heart Failure? Circ Res. 2001; 89: 201-210.
- Laronha H., Carpinteiro I., Portugal J., et al. Challenges in Matrix Metalloproteinases Inhibition. Biomolecules. 2020; 10 (5); 717.
- Григоркевич О.С., Мокров Г.В., Дябина А.С. и др. Дизайн, синтез и фармакологическая активность нового ингибитора матриксной металлопротеиназы-9. Химико-фармацевтический журнал. 2018; 52(1): 8-14.
- Середенин С.Б., Мокров Г.В., Крыжановский С.А., Лихошерстов А.М. и др. Ингибиторы цинк-зависимых металлопротеиназ (ММП-2 и ММП-9) в ряду бензоиламино(фенилсульфонил)-замещенных циклических аминокислот как потенциальные лекарственные средства, препятствующие постинфарктному ремоделированию левого желудочка сердца. Патент РФ № 2646752. 2016.
- Faust A. Waschkau B., Waldeck J., et al. Synthesis and Evaluation of a Novel Fluorescent Photoprobe for Imaging Matrix Metalloproteinases. Bioconjugate Chem. 2008; 19: 1001-1008.
- Cerisano G., Buonamici P., Gori A.M., et al. Matrix metallo-proteinases and their tissue inhibitor after reperfused ST-elevation myocardial infarction treated with doxycycline. Insights from the TIPTOP trial. Int. J. Cardiol. 2015; 197: 147153.
补充文件
